Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Brain Neoplasms
×
tucatinib
×
Clear all
Filters
3
NCT02614794
2023-08-14
HER2CLIMB
Seagen Inc.
Phase 2
Completed
612 enrolled
30 charts
2 FDA